Moody’s affirms Novo Nordisk

Moody's Investors Service said it affirmed Novo Nordisk A/S' A1 long-term issuer rating and P-1 short-term issuer rating, as well as the A1 backed senior unsecured ratings of Novo Nordisk Finance (Netherlands) BV, a subsidiary of Novo Nordisk.

The outlook on both entities remains stable.

“Today's affirmation of Novo Nordisk's A1 ratings reflects Moody's expectations that the company's credit metrics will remain very strong after the planned acquisition of three manufacturing sites for a consideration of $11 billion, and that Novo Nordisk will remain strongly positioned at A1,” the agency said in a news release.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.